Get Wall Street analysts ratings for Pfizer Inc. (PFE). Buy or Sell this stock? See what the analysts say. Ratings values: · Strong Buy = 5 · Moderate Buy = 4 · Hold = 3 · Moderate Sell = 2 · Strong Sell = 1. According to 14 analysts, the average rating for PFE stock is "Buy." The 12 Top 10 pharmaceutical companies in S&P Global's latest ratings and rankings. PFE - Pfizer - Stock Forecast PFE is currently covered by 18 analysts with an average price target of $ This is a potential upside of $ (%). Analysts' Consensus ; Mean consensus. OUTPERFORM ; Number of Analysts. 25 ; Last Close Price. USD ; Average target price. USD ; Spread / Average Target. +.
Seeking Alpha's authors provide a stock rating for Pfizer Inc. (PFE). Ratings range from 'Very Bullish' to 'Very Bearish'. We are holding steady to our $42 fair value estimate for Pfizer following slightly better-than-expected second-quarter results. We continue to view the. Pfizer Inc has a consensus price target of $41 based on the ratings of 23 analysts. The high is $60 issued by Goldman Sachs on December 13, The latest consensus rating for Pfizer is "Hold". This is the average recommendation of 30 analysts: 0 strong sell, 0 sell, 18 hold, 8 buy, 4 strong buy. In the. On average, Wall Street analysts predict that Pfizer's share price could reach $ by Aug 19, The average Pfizer stock price prediction forecasts a. The average analyst rating for Pfizer stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over. %. Analyst Ratings. Average price target from 26 ratings: $ Average score: Sell. Under. Hold. Over. Buy. Full Ratings · StockGrader. Rating: Qualitative analysis on Morningstar's global equity coverage. Analyst commentary, star ratings and economic moat evaluations. Morningstar's Rating Scale. Get Pfizer Inc (PFE:NYSE) real-time stock quotes, news, price and financial information from CNBC. Pfizer (PFE) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.. Is Pfizer stock a Buy, Sell or Hold? Pfizer stock has received a consensus rating of hold. The average rating score is A2 and is based on 33 buy ratings.
Analyst Ratings of PFIZER INC(NYSE:PFE) stock. Analyst ratings, forecast, price target, upgrades and downgrades. Pfizer Inc. ; Average Recommendation, Overweight ; Average Target Price, ; Number Of Ratings, 26 ; FY Report Date, 12/ ; Last Quarter's Earnings, 26 analyst ratings ; buy 38% ; hold 62% ; sell 0%. Ratings Values: ; Strong Buy5 ; Moderate Buy4 ; Hold3 ; Moderate Sell2 ; Strong Sell1. Based on 15 Wall Street analysts who have issued ratings for Pfizer in the last 12 months, the stock has a consensus rating of "Moderate Buy. Analyst's Opinion. Consensus Rating. Pfizer has received a consensus rating of Moderate Buy. The company's average rating score is , and is based on 6 buy. Pfizer Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PFE updated stock price target summary. Broker Rating. Pfizer currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on. Based on 26 analysts giving stock ratings to PFE in the past 3 months. Neutral. SellBuy. Strong sellStrong buy.
Seeking Alpha's authors provide a stock rating for Pfizer Inc. (PFE). Ratings range from 'Very Bullish' to 'Very Bearish'. See Pfizer Inc. (PFE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Why Are Analyst Ratings important? In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that. Pfizer Inc's average analyst rating is Strong Buy. Stock Target Advisor's own stock analysis of Pfizer Inc is Bearish, which is based on 4 positive signals and. PFE analyst stock forecast, price target, and recommendation Analyst Report: Pfizer Inc. Bullish. Rating:Maintained. Price.
Why You Have to Buy Pfizer (PFE) Now!! - Pfizer Stock Analysis
Pfizer Analyst Ratings · Jul 1 ; Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target · Jul 1 ; Pfizer Analyst Ratings · Jun Pfizer, Inc.: Financial analyst guidance for Pfizer, Inc. Stock | Nyse: PFE | Nyse. PFE Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow 35% per year · Trading at good value compared to peers. We've gathered analysts' opinions on Pfizer future price: according to them, PFE price has a max estimate of USD and a min estimate of USD. Watch. PFE has a lower variance in analysts' estimates than % of stocks in the mega market cap category. In terms of price targets and recommendations offered.